BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27023784)

  • 21. Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis.
    Filippakis H; Belaid A; Siroky B; Wu C; Alesi N; Hougard T; Nijmeh J; Lam HC; Henske EP
    Sci Rep; 2018 Sep; 8(1):14161. PubMed ID: 30242175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.
    Alayev A; Sun Y; Snyder RB; Berger SM; Yu JJ; Holz MK
    Cell Cycle; 2014; 13(3):371-82. PubMed ID: 24304514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
    Kishore R; Krishnamurthy P; Garikipati VN; Benedict C; Nickoloff E; Khan M; Johnson J; Gumpert AM; Koch WJ; Verma SK
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):203-13. PubMed ID: 26549357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
    Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
    Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.
    Grevengoed TJ; Cooper DE; Young PA; Ellis JM; Coleman RA
    FASEB J; 2015 Nov; 29(11):4641-53. PubMed ID: 26220174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.
    Parkhitko A; Myachina F; Morrison TA; Hindi KM; Auricchio N; Karbowniczek M; Wu JJ; Finkel T; Kwiatkowski DJ; Yu JJ; Henske EP
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12455-60. PubMed ID: 21746920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell-penetrating ester of the neural metabolite lanthionine ketimine stimulates autophagy through the mTORC1 pathway: Evidence for a mechanism of action with pharmacological implications for neurodegenerative pathologies.
    Harris-White ME; Ferbas KG; Johnson MF; Eslami P; Poteshkina A; Venkova K; Christov A; Hensley K
    Neurobiol Dis; 2015 Dec; 84():60-8. PubMed ID: 25779968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
    Chen Y; Wei H; Liu F; Guan JL
    J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
    Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
    BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period.
    Tamai T; Yamaguchi O; Hikoso S; Takeda T; Taneike M; Oka T; Oyabu J; Murakawa T; Nakayama H; Uno Y; Horie K; Nishida K; Sonenberg N; Shah AM; Takeda J; Komuro I; Otsu K
    J Biol Chem; 2013 Apr; 288(14):10176-10187. PubMed ID: 23426372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway.
    Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM
    Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.
    Bai Y; Xuan B; Liu H; Zhong J; Yu D; Qian Z
    J Virol; 2015 Aug; 89(15):7625-35. PubMed ID: 25972538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
    Rolfe M; McLeod LE; Pratt PF; Proud CG
    Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling.
    Wang RH; He JP; Su ML; Luo J; Xu M; Du XD; Chen HZ; Wang WJ; Wang Y; Zhang N; Zhao BX; Zhao WX; Shan ZG; Han J; Chang C; Wu Q
    EMBO Mol Med; 2013 Jan; 5(1):137-48. PubMed ID: 23197407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
    Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
    Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.
    Lam HC; Baglini CV; Lope AL; Parkhitko AA; Liu HJ; Alesi N; Malinowska IA; Ebrahimi-Fakhari D; Saffari A; Yu JJ; Pereira A; Khabibullin D; Ogorek B; Nijmeh J; Kavanagh T; Handen A; Chan SY; Asara JM; Oldham WM; Diaz-Meco MT; Moscat J; Sahin M; Priolo C; Henske EP
    Cancer Res; 2017 Jun; 77(12):3255-3267. PubMed ID: 28512249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation.
    Cao J; Tyburczy ME; Moss J; Darling TN; Widlund HR; Kwiatkowski DJ
    J Clin Invest; 2017 Jan; 127(1):349-364. PubMed ID: 27918305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.
    Zhang J; Kim J; Alexander A; Cai S; Tripathi DN; Dere R; Tee AR; Tait-Mulder J; Di Nardo A; Han JM; Kwiatkowski E; Dunlop EA; Dodd KM; Folkerth RD; Faust PL; Kastan MB; Sahin M; Walker CL
    Nat Cell Biol; 2013 Oct; 15(10):1186-96. PubMed ID: 23955302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.